Almstead Neil Gregory sold PTCT
March 5, 2026 · Form 4 insider transaction
Almstead Neil Gregory sold 3,989 shares of PTC Therapeutics, Inc. at $63.38 per share, a transaction worth $252.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,989
Price
$63.38
Total value
$252.8K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after2,737
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 26, 2025.